Cancer of the prostate treated with 1 mg per day of diethylstilbestrol. Value of the determination of salivary free testosterone
Steg, A.; Laudat, M.H.; Zerbib, M.; Guiban, D.
Presse Medicale 17(6): 282
1988
ISSN/ISBN: 0755-4982 PMID: 2964628 Document Number: 319278
Document emailed within 1 workday
Related Documents
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747Swinkels, L.M.; van Hoof, H.J.; Ross, H.A.; Smals, A.G.; Benraad, T.J. 1991: Concentrations of salivary testosterone and plasma total, non-sex-hormone-binding globulin-bound, and free testosterone in normal and hirsute women during administration of dexamethasone/synthetic corticotropin Clinical Chemistry 37(2): 180-185
Yonemura, C.Y.; Cunha, G.R.; Sugimura, Y.; Mee, S.L. 1995: Temporal and spatial factors in diethylstilbestrol-induced squamous metaplasia in the developing human prostate. II. Persistent changes after removal of diethylstilbestrol Acta Anatomica 153(1): 1-11
Rosser, C.J.; Kuban, D.A.; Lee, S-Joon.; Levy, L.B.; Pettaway, C.; Kamat, A.M.; Chichakli, R.; Lee, A.; Cheung, R.M.; Sanchez-Ortiz, R.; Pisters, L.L. 2004: Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer Journal of the National Medical Association 96(7): 939-944
König, B.; Ivankovic, B.; Schleff, R.; Mack, M. 1999: Liaison free PSA--an automated chemiluminescent immunoassay for the determination of free prostate specific antigen (fPSA) Anticancer Research 19(4A): 2763-2765
Maeda, H.; Arai, Y.; Ishitoya, S.; Okubo, K.; Aoki, Y.; Okada, T.; Maekawa, S. 1998: Free-to-total prostate specific antigen ratio in clinical staging of prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 44(5): 307-311
De la Taille, A.; Houlgatte, A.; Houdelette, P.; Berlizot, P.; Ramirez, J.; Ricordel, I. 1997: Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients) Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(2): 240-245
Damian, E.; Ianăş, O.; Bădescu, I. 1987: Effect of melatonin-free pineal extract on acid phosphatase activity in the testosterone-treated, castrated rat Endocrinologie 25(1): 9-14
Jensen, C.F.S.; Fode, M.; Østergren, P.; Sønksen, J. 2017: Testosterone replacement therapy for hypogonadism in men with prostate cancer Ugeskrift for Laeger 179(9)
Fornara, P.; Sturm, W.; Fabricius, P.G.; Schmiedt, E. 1987: Clinical relevance of radioimmunologic determination of prostate specific antigen in prostate cancer Der Urologe. Ausg. a 26(3): 158-161
Kley, H.K.; Bartmann, E.; Krüskemper, H.L. 1977: The measurement of free cortisol, free testosterone and free oestradiol-17beta: a comparison of five different methods Journal of Clinical Chemistry and Clinical Biochemistry 15(9): 465-472
Wu, C.T.; Chuang, C.K.; Chou, C.C.; Chu, S.H.; Chen, H.W.; Chen, C.S.; Chiang, Y.J.; Liao, S.K. 2000: The role of free to total prostate-specific antigen ratio for prostate cancer in screening patients with total serum levels between 4 and 20 ng/ml Chang Gung Medical Journal 23(3): 142-148
Li, T.; Xu, L.; Liu, Y.; Liu, X.; Kang, D.; Qiu, D.; Han, D. 2013: Correlation analysis between serum free testosterone and total testosterone in Chengdu females Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 30(2): 355-358
Ide, H.; Yasuda, M.; Nishio, K.; Saito, K.; Isotani, S.; Kamiyama, Y.; Muto, S.; Horie, S. 2008: Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels Anticancer Research 28(4c): 2487-2492
Karamanolakis, D.; Lambou, T.; Bogdanos, J.; Milathianakis, C.; Sourla, A.; Lembessis, P.; Halapas, A.; Pissimissis, N.; Dessypris, N.; Petridou, E.T.; Koutsilieris, M. 2006: Serum testosterone: a potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (> or =3.0 and <10.0 ng/ml) Anticancer Research 26(4b): 3159-3166
Shain, S.A.; Boesel, R.W.; Kalter, S.S.; Heberling, R.L. 1981: A x C rat prostate adenocarcinoma: initial characterization of testosterone regulation of hormone receptors of cultured cancer cells and derived tumors Journal of the National Cancer Institute 66(3): 565-574
Sinitsyn, P.V.; Varga, S.V.; Reznikov, A.G. 1988: Diethylstilbestrol potentiation of the antiandrogenic effects of niftolide in the prostate Farmakologiia i Toksikologiia 51(4): 75-77
Yang, Y.W.; Wu, R.J. 1992: Trimethylsilylation of testosterone, epi-testosterone and determination of their ratio in urine by GC-MS Yao Xue Xue Bao 27(10): 758-762
Jinrui, H.; Itoh, N.; Nitta, T.; Kurohata, T.; Tsukamoto, T.; Kumamoto, Y.; Umehara, T. 1994: Changes in the salivary testosterone level in aged Hinyokika Kiyo. Acta Urologica Japonica 40(9): 807-811
Tarle, M.; Kraus, O.; Trnski, D.; Reljic, A.; Ruzic, B.; Katusic, J.; Spajic, B.; Kusic, Z. 2003: Early diagnosis of prostate cancer in finasteride treated BPH patients Anticancer Research 23(1b): 693-696